Loading organizations...
Loading organizations...
Cancer immunotherapy company using synthetic biology and gene engineering.
Refuge Biotechnologies has raised $25.0M across 1 funding round.
Refuge Biotechnologies has raised $25.0M in total across 1 funding round.
Refuge Biotechnologies has raised $25.0M in total across 1 funding round.
Refuge Biotechnologies's investors include Dr. Jing Lou, Neil Shen, 3E Bioventures Capital, Danhua Capital, Ocean Pine Healthcare Fund, Sangel Capital, ShangBay Capital, WuXi Healthcare Ventures.
Refuge Biotechnologies has raised $25.0M across 1 funding round. Most recently, it raised $25.0M Series B in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 2, 2018 | $25.0M Series B | Dr. Jing Lou, Neil Shen | 3E Bioventures Capital, Danhua Capital, Ocean Pine Healthcare Fund, Sangel Capital, ShangBay Capital, WuXi Healthcare Ventures |